Bio-Techne Corporation (NasdaqGS:TECH) will look for M&A. James Hippel, Chief Financial Officer said, "One is I think our rate of investments could increase. Once we hit that 40% mark, it can continue to grow to feed growth for the next 5, 10 years. But also, we will do more M&A. And not all M&A is going to be accretive.

In fact, almost no M&A is going to be accretive like Wilson Wolf. So kind of set the expectations that something around 40% or maybe even sub-40s long term what's in the cards with including M&A".